Radiologic findings following Y90 radioembolization for primary liver malignancies

Abdominal Imaging

Volumn 34, Issue 5, 2009, Pages 566-581

  Ibrahim, Saad M ^a   Nikolaidis, Paul ^a   Miller, Frank H ^a   Lewandowski, Robert J ^a   Ryu, Robert K ^a   Sato, Kent T ^a   Senthilnathan, Sean ^a   Riaz, Ahsun ^a   Kulik, Laura ^b   Mulcahy, Mary F ^b   Omary, Reed A ^a   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Internal radiation; Radioembolization; Selective; SIR Spheres; TheraSphere; Yttrium 90

Indexed keywords

FLUORODEOXYGLUCOSE F 18; YTTRIUM 90;

ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; CHOLECYSTITIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DUODENUM ULCER; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR NECROSIS;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EMBOLIZATION, THERAPEUTIC; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICROSPHERES; PATIENT SELECTION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; YTTRIUM RADIOISOTOPES;

EID: 69249229686     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-008-9454-y     Document Type: Review

References (55)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. HB El-Serag 2002 Hepatocellular carcinoma: an epidemiologic view J Clin Gastroenterol 35 S72 S78
3. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557 2576
4. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236
5. K Sato RJ Lewandowski JT Bui, et al. 2006 Treatment of unresectable primary and metastatic liver cancer with Yttrium-90 microspheres (TheraSphere(R)): assessment of hepatic arterial embolization Cardiovasc Intervent Radiol 29 522 529
6. R Salem KG Thurston 2006 Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations J Vasc Interv Radiol 17 1251 1278 (Pubitemid 44259009)
7. R Salem KG Thurston BI Carr, et al. 2002 Yttrium-90 microspheres: radiation therapy for unresectable liver cancer J Vasc Interv Radiol 13 S223 S229
8. JE Dancey FA Shepherd K Paul, et al. 2000 Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres J Nucl Med 41 1673 1681
9. JL Russell JL Carden HL Herron 1988 Dosimetry calculations for yttrium-90 used in the treatment of liver cancer Endocurietherapy/Hyperthermia Oncol 4 171 186
10. R Salem KG Thurston 2006 Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 2: special topics J Vasc Interv Radiol 17 1425 1439 (Pubitemid 44412994)
11. A Kennedy S Nag R Salem, et al. 2007 Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 13 23
12. SM Ibrahim RJ Lewandowski KT Sato, et al. 2008 Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review World J Gastroenterol 14 1664 1669
13. AM Covey LA Brody MA Maluccio, et al. 2002 Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients Radiology 224 542 547
14. PJ Allen A Stojadinovic L Ben-Porat, et al. 2002 The management of variant arterial anatomy during hepatic arterial infusion pump placement Ann Surg Oncol 9 875 880
15. BI Carr 2002 Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients Hepatogastroenterology 49 79 86
16. HJ Chun JY Byun SS Yoo BG Choi 2003 Added benefit of thoracic aortography after transarterial embolization in patients with hemoptysis AJR 180 1577 1581
17. R Arora MC Soulen ZJ Haskal 1999 Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals J Vasc Interv Radiol 10 1351 1356
18. K Ueno N Miyazono H Inoue, et al. 1995 Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma Cardiovasc Intervent Radiol 18 183 185
19. Y Inaba Y Arai K Matsueda, et al. 2001 Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy J Vasc Interv Radiol 12 957 963
20. JW Chung JH Park JK Han, et al. 1996 Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 33 40
21. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
22. AL Keppke R Salem D Reddy, et al. 2007 Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres AJR 188 768 775 (Pubitemid 46303204)
23. B Atassi AK Bangash A Bahrani, et al. 2008 Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay Radiographics 28 81 99
24. LM Kulik B Atassi L van Holsbeeck, et al. 2006 Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 572 586
25. R Salem RJ Lewandowski B Atassi, et al. 2005 Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 1627 1639
26. B Sangro JI Bilbao J Boan, et al. 2006 Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma Int J Radiat Oncol Biol Phys 66 792 800
27. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430
28. LM Kulik BI Carr MF Mulcahy, et al. 2008 Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 71 81
29. E Liapi JF Geschwind JA Vossen, et al. 2008 Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization AJR 190 67 73
30. J Deng FH Miller TK Rhee, et al. 2006 Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization J Vasc Interv Radiol 17 1195 1200
31. J Deng S Virmani J Young, et al. 2008 Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits J Magn Reson Imaging 27 1069 1076
32. IR Kamel DA Bluemke D Ramsey, et al. 2003 Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma AJR 181 708 710
33. I Sarikaya M Bloomston SP Povoski, et al. 2007 FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA World J Surg Oncol 5 64
34. FH Miller AL Keppke D Reddy, et al. 2007 Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET AJR 188 776 783
35. AS Kennedy D Coldwell C Nutting, et al. 2006 Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 412 425
36. KT Sato RJ Lewandowski MF Mulcahy, et al. 2008 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy, and survival Radiology 247 507 515
37. SA Khan BR Davidson R Goldin, et al. 2002 Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 51 Suppl 6 VI1 9
38. LM Kulik MF Mulcahy RD Hunter, et al. 2005 Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report Liver Transpl 11 1127 1131
39. Lewandowski R, Salem R, Thurston K, et al. (2004) Radiation segmentectomy of unresectable of liver carcinoma using selective infusion of intraarterial Yttrium-90 theraSphere. Radiological Society of North America, Chicago
40. TK Rhee RA Omary V Gates, et al. 2005 The effect of catheter-directed CT angiography on Yttrium-90 radioembolization treatment of hepatocellular carcinoma J Vasc Interv Radiol 16 1085 1091
41. TF Jakobs S Saleem B Atassi, et al. 2008 Fibrosis, portal hypertension, hepatic volume changes induced by intra-arterial radiotherapy with (90)Yttrium microspheres Dig Dis Sci 53 9 2556 2563
42. D Cherqui L Palazzo P Piedbois, et al. 1994 Common bile duct stricture as a late complication of upper abdominal radiotherapy J Hepatol 20 693 697
43. Y Nakakubo S Kondo H Katoh, et al. 2000 Biliary stricture as a possible late complication of radiation therapy Hepatogastroenterology 47 1531 1532
44. DM Liu R Salem JT Bui, et al. 2005 Angiographic considerations in patients undergoing liver-directed therapy J Vasc Interv Radiol 16 911 935
45. I Sakamoto S Iwanaga K Nagaoki, et al. 2003 Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization AJR 181 79 87
46. B Atassi AK Bangash RJ Lewandowski, et al. 2008 Biliary sequelae following radioembolization with yttrium-90 microspheres J Vasc Interv Radiol 19 691 697
47. R Murthy DB Brown R Salem, et al. 2007 Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy J Vasc Interv Radiol 18 553 561 quiz 62
48. RJ Lewandowski KT Sato B Atassi, et al. 2007 Radioembolization with (90)y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 571 592 (Pubitemid 350092259)
49. R Salem RJ Lewandowski KT Sato, et al. 2007 Technical aspects of radioembolization with 90Y microspheres Tech Vasc Interv Radiol 10 12 29
50. JA Ingold GB Reed HS Kaplan MA Bagshaw, et al. 1965 Radiation hepatitis Am J Roentgenol Radium Ther Nucl Med 93 200 208
51. TS Lawrence JM Robertson MS Anscher, et al. 1995 Hepatic toxicity resulting from cancer treatment Int J Radiat Oncol Biol Phys 31 1237 1248
52. B Sangro B Gil-Alzugaray J Rodriguez, et al. 2008 Liver disease induced by radioembolization of liver tumors: description and possible risk factors Cancer 112 1538 1546
53. JY Young TK Rhee B Atassi, et al. 2007 Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma J Vasc Interv Radiol 18 1375 1382
54. JM Llovet M Beaugrand 2003 Hepatocellular carcinoma: present status and future prospects J Hepatol 38 Suppl 1 S136 S149
55. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442